DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Theobromine is an investigational drug.
There have been 4 clinical trials for Theobromine. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2015.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Diabetes Mellitus, Type 2, and Cough. The leading clinical trial sponsors are Centre hospitalier de l'Université de Montréal (CHUM), Canadian Institutes of Health Research (CIHR), and Respicopea Limited.
There are two US patents protecting this investigational drug and twenty-one international patents.
Recent Clinical Trials for Theobromine
|Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?||Gottfried und Julia Bangerter-Rhyner Foundation, Switzerland||N/A|
|Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?||Thomas Steffen||N/A|
|Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects||Canadian Institutes of Health Research (CIHR)||Phase 4|
Top disease conditions for Theobromine
Top clinical trial sponsors for Theobromine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Theobromine||See Pricing||Antiviral drugs for treatment of arenavirus infection||Kineta Viral Hemorrhagic Fever, LLC (Seattle, WA)||See Pricing|
|Theobromine||See Pricing||Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers||eFFECTOR Therapeutics, Inc. (San Diego, CA)||See Pricing|
|Theobromine||See Pricing||Methyl diazepane orexin receptor antagonists||Merck Sharp & Dohme Corp. (Rahway, NJ)||See Pricing|
|Theobromine||See Pricing||Inhibitors of HIF prolyl hydroxylase||Merck Sharp & Dohme Corp. (Rahway, NJ)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Theobromine||African Regional IP Organization (ARIPO)||3675||2032-02-17||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|